Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL997 (Bondenza, Bondronat, Boniva, Bonviva, Iasibon, Ibandronate, Ibandronic acid, Ibandronic Acid, Ibandronic acid accord, Ibandronic acid sandoz, Ibandronic acid teva, NSC-722623, Quodixor) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
farnesyl diphosphate synthase/Farnesyl diphosphate synthase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1782] [GtoPdb: 644] [UniProtKB: P14324] | ||||||||
ChEMBL | Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 | B | 6.71 | pKi | 195 | nM | Ki | J Med Chem (2008) 51: 2187-2195 [PMID:18327899] |
GtoPdb | - | - | 6.71 | pKi | 195 | nM | Ki | J Med Chem (2008) 51: 2187-95 [PMID:18327899] |
ChEMBL | Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand | B | 7.34 | pKi | 46 | nM | Ki | J Med Chem (2003) 46: 5171-5183 [PMID:14613320] |
ChEMBL | Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins | B | 8.44 | pKi | 3.6 | nM | Ki | J Med Chem (2008) 51: 2187-2195 [PMID:18327899] |
ChEMBL | Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 | B | 5.98 | pIC50 | 1052 | nM | IC50 | J Med Chem (2008) 51: 2187-2195 [PMID:18327899] |
ChEMBL | Inhibitory activity against farnesyl Pyrophosphate Synthase was determined | B | 6.32 | pIC50 | 480 | nM | IC50 | J Med Chem (2003) 46: 5171-5183 [PMID:14613320] |
ChEMBL | Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M) | B | 6.32 | pIC50 | 478.63 | nM | IC50 | J Med Chem (2003) 46: 5171-5183 [PMID:14613320] |
ChEMBL | Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins | B | 7.6 | pIC50 | 25.4 | nM | IC50 | J Med Chem (2008) 51: 2187-2195 [PMID:18327899] |
ChEMBL | Inhibitory activity against the human recombinant FPPSase (Farnesyl diphosphate) enzyme | B | 7.7 | pIC50 | 20 | nM | IC50 | J Med Chem (2002) 45: 2185-2196 [PMID:12014956] |
farnesyl diphosphate synthase in Rat [GtoPdb: 644] [UniProtKB: P05369] | ||||||||
GtoPdb | in vitro using kidney cell lines | - | 5.13 | pIC50 | 7400 | nM | - | Toxicol In Vitro (2008) 22: 899-909 [PMID:18325729] |
geranylgeranyl diphosphate synthase/Geranylgeranyl pyrophosphate synthetase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4769] [GtoPdb: 643] [UniProtKB: O95749] | ||||||||
ChEMBL | Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase). | B | 4.08 | pIC50 | 83000 | nM | IC50 | J Med Chem (2002) 45: 2185-2196 [PMID:12014956] |
ChEMBL | Inhibition of human recombinant geranylgeranyl diphosphate synthase | B | 4.1 | pIC50 | 79432.82 | nM | IC50 | J Med Chem (2008) 51: 5594-5607 [PMID:18800762] |
ChEMBL | Inhibition of human recombinant geranylgeranyl diphosphate synthase | B | 4.1 | pIC50 | 79430 | nM | IC50 | J Med Chem (2008) 51: 5594-5607 [PMID:18800762] |
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Growth inhibition of Plasmodium falciparum | F | 4.1 | pIC50 | 79432.82 | nM | IC50 | J Med Chem (2008) 51: 7827-7833 [PMID:19053772] |
ChEMBL | Growth inhibition of Plasmodium falciparum | F | 4.13 | pIC50 | 74000 | nM | IC50 | J Med Chem (2008) 51: 7827-7833 [PMID:19053772] |
ChEMBL | Antimicrobial activity against Plasmodium falciparum | F | 4.23 | pIC50 | 59000 | nM | IC50 | Bioorg Med Chem (2010) 18: 2225-2231 [PMID:20185316] |
squalene synthase /Squalene synthetase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3815] [GtoPdb: 645] [UniProtKB: Q02769] | ||||||||
GtoPdb | Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting | - | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2010) 18: 2428-38 [PMID:20299227] |
ChEMBL | Inhibition of squalene synthase in rat liver microsomes assessed as conversion of [1-3H]FPP to [3H]squalene level after 60 mins by liquid scintillation counting | B | 6.19 | pIC50 | 640 | nM | IC50 | Bioorg Med Chem (2010) 18: 2428-2438 [PMID:20299227] |
ChEMBL data shown on this page come from version 32:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]